2017
DOI: 10.1186/s13229-017-0122-3
|View full text |Cite
|
Sign up to set email alerts
|

Glutathione metabolism in the prefrontal brain of adults with high-functioning autism spectrum disorder: an MRS study

Abstract: BackgroundAutism spectrum disorder (ASD) is a neurodevelopmental disease characterized by difficulties in social communication, unusually restricted, repetitive behavior and interests, and specific abnormalities in language and perception. The precise etiology of ASD is still unknown and probably heterogeneous. In a subgroup of patients, toxic environmental exposure might lead to an imbalance between oxidative stress and anti-oxidant systems. Previous serum and postmortem studies measuring levels of glutathion… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
28
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 36 publications
(32 citation statements)
references
References 70 publications
4
28
0
Order By: Relevance
“…We included 36 patients with ASD who had received a lumbar puncture at our tertiary care hospital from 2010 to 2018. The patients were diagnosed by experienced senior physicians following German guidelines [ 30 ] as described in detail in earlier papers [ 31 , 32 ] and were classified following ICD-10. Patients with neurodegenerative disorders were excluded from the study; examples include mild cognitive impairment (ICD-10: F06.7) or dementia (ICD-10: F03), substance abuse (ICD-10: F1x.2), or severe neurological diseases other than epilepsy (because of its known association with ASD) [ 33 , 34 ].…”
Section: Participants and Methodsmentioning
confidence: 99%
“…We included 36 patients with ASD who had received a lumbar puncture at our tertiary care hospital from 2010 to 2018. The patients were diagnosed by experienced senior physicians following German guidelines [ 30 ] as described in detail in earlier papers [ 31 , 32 ] and were classified following ICD-10. Patients with neurodegenerative disorders were excluded from the study; examples include mild cognitive impairment (ICD-10: F06.7) or dementia (ICD-10: F03), substance abuse (ICD-10: F1x.2), or severe neurological diseases other than epilepsy (because of its known association with ASD) [ 33 , 34 ].…”
Section: Participants and Methodsmentioning
confidence: 99%
“…The spectroscopic analysis was conducted as described in earlier studies [1517, 55, 57]. We used the linear combination of model spectra (LCModel) algorithm to ensure investigator-independent spectral analysis [44, 45].…”
Section: Participants and Methodsmentioning
confidence: 99%
“…Hence, although the overall trend is for lower GABA+ in ASD, it seems that results are inconsistent, owing perhaps to differences in experimental procedures and analysis methods, regions of interest (ROIs), and sample characteristics, as summarized in several recent reviews [Ajram et al, 2019;Ford & Crewther, 2016;Schür et al, 2016]. In the case of Glx, results are even less conclusive, with studies reporting reduced [Bernardi et al, 2011;Corrigan et al, 2013;DeVito et al, 2007;Hegarty et al, 2018;Horder et al, 2013Horder et al, , 2018Kubas et al, 2012;Tebartz Van Elst et al, 2014], equivalent [Ajram et al, 2017;Aoki et al, 2012;Brix et al, 2015;Carvalho Pereira et al, 2018;Endres et al, 2017;Friedman et al, 2006;Goji et al, 2017;Hardan et al, 2008;Horder et al, 2018;Ito et al, 2017;Libero et al, 2016;Mikkelsen et al, 2017;Robertson et al, 2016], or increased [Bejjani et al, 2012;Brown, Singel, Hepburn, & Rojas, 2013;Doyle-Thomas et al, 2014;Page et al, 2006] levels in ASD. In the current study, we sought to extend previous results by measuring GABA+ and Glx simultaneously using current methodology, in a relatively large sample of well-characterized individuals with ASD, including previously unexamined ROIs, and testing the functional relevance of neurometabolite levels by correlating individual differences in MRS measures with behavior and ASD symptomatology.…”
Section: Introductionmentioning
confidence: 99%